Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
ESMO: In PD-1 battle GSK waged on Merck, Jemperli appears to show survival edge over Keytruda in lung cancer
Fierce Pharma
Fri, 10/20/23 - 11:47 am
Merck
GSK
Keytruda
Jemperli
ESMO
nonsquamous non-small cell lung cancer
ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer
Fierce Pharma
Wed, 10/18/23 - 11:42 am
Seagen
Astellas
Merck
Padcev
Keytruda
bladder cancer
ESMO
Merck Pushes Keytruda into Perioperative NSCLC Setting with FDA Approval
BioSpace
Tue, 10/17/23 - 09:36 pm
Merck
Keytruda
non-small cell lung cancer
Merck's Keytruda hits overall survival goal in early lung cancer as FDA decision nears
Fierce Pharma
Tue, 10/10/23 - 10:18 am
Merck
Keytruda
non-small cell lung cancer
Merck eyes new bladder cancer space with positive Keytruda trial in muscle-invasive disease
Fierce Pharma
Thu, 10/5/23 - 09:03 pm
Merck
Keytruda
bladder cancer
muscle-invasive urothelial carcinoma
Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
BioSpace
Fri, 09/22/23 - 11:53 am
Merck
Seagen
Astellas
urothelial cancer
clinical trials
bladder cancer
Padcev
Keytruda
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Merck
Eisai
Keytruda
Lenvima
melanoma
colorectal cancer
non-small cell lung cancer
Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag
Yahoo/Zacks.com
Thu, 09/21/23 - 06:32 pm
Merck
Keytruda
FDA
cervical cancer
priority review
1ST Biotherapeutics and Merck to assess cancer combination treatment
Clinical Trials Arena
Wed, 09/20/23 - 11:09 pm
Merck
1st Biotherapeutics
Keytruda
solid tumors
clinical trials
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Sun, 08/27/23 - 04:40 pm
Merck
Eisai
Keytruda
Lenvima
clinical trials
head and neck cancer
Merck’s Keytruda to top drug sales in 2028, as Roche takes pharma crown
Medical Marketing and Media
Fri, 08/25/23 - 09:55 am
Merck
Keytruda
Roche
branding
Merck's Keytruda will top pharma's sales rankings in 2028, with Roche taking the company category crown
Fierce Pharma
Mon, 08/21/23 - 10:52 am
Merck
Roche
pharma sales
Keytruda
Gilead antibody drug shows signs of potential in early lung cancer
BioPharma Dive
Thu, 08/17/23 - 10:03 am
Gilead Sciences
Trodelvy
Merck
Keytruda
lung cancer
Eli Lilly meets primary endpoint in LIBRETTO-431 study for NSCLC
Clinical Trials Arena
Mon, 08/7/23 - 10:25 am
Eli Lilly
clinical trials
Retevmo
non-small cell lung cancer
Keytruda
Moderna plots lung cancer trial for Merck-partnered vax, piggybacking on Keytruda's recent win
Fierce Biotech
Wed, 08/2/23 - 10:50 pm
Moderna Therapeutics
lung cancer
Merck
vaccines
Keytruda
Merck's Keytruda meets main goal in late-stage breast cancer study
Reuters
Sat, 07/29/23 - 10:40 pm
Merck
Keytruda
clinical trials
breast cancer
Moderna/Merck begins late-stage study of skin cancer vaccine combination
Yahoo/Reuters
Wed, 07/26/23 - 09:36 am
Moderna Therapeutics
Merck
MRNA
vaccines
skin cancer
Keytruda
clinical trials
Phase III Data Show Keytruda’s Promise in Earlier-Stage Cervical Cancer
BioSpace
Wed, 07/19/23 - 10:21 am
Merck
Keytruda
clinical trials
cervical cancer
Keytruda Keeps Racking Up Approvals and Clinical Wins in ’23
BioSpace
Thu, 07/6/23 - 11:30 am
Merck
Keytruda
oncology
cancer
After metastatic disease win, Merck's Keytruda flunks trial in early stomach cancer
Fierce Pharma
Tue, 06/20/23 - 09:39 pm
Merck
Keytruda
stomach cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »